Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Martinelli

Showing results (81-90 of 101) with videos related to

Pageof 11
Sort By:
Lupus|October 10, 2014
Acute longitudinal myelitis following Cryptococcus laurentii pneumonia in a patient with systemic lupus erythematosusF Conti, F R Spinelli, S Colafrancesco, et al.
Molecular Neurobiology|June 28, 2021
Transcriptomic Analysis of Peripheral Monocytes upon Fingolimod Treatment in Relapsing Remitting Multiple Sclerosis PatientsG Sferruzza, F Clarelli, E Mascia, et al.
Oncogene|June 17, 2014
Antisense transcription at the TRPM2 locus as a novel prognostic marker and therapeutic target in prostate cancerU Orfanelli, E Jachetti, F Chiacchiera, et al.
Journal of Neurology|February 14, 2018
Effectiveness and baseline factors associated to fingolimod response in a real-world study on multiple sclerosis patientsF Esposito, L Ferrè, F Clarelli, et al.
Multiple Sclerosis and Related Disorders|July 28, 2018
Neuromyelitis optica spectrum disorder and multiple sclerosis in a Sardinian familyS Gelibter, B Mazzi, M Tassara, et al.
Neurology|June 17, 1999
Relevance of interleukin 1 receptor antagonist intron 2 polymorphism in Italian MS patientsF L Sciacca, C Ferri, K Vandenbroeck, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|May 15, 2018
Basal vitamin D levels and disease activity in multiple sclerosis patients treated with fingolimodL Ferre', F Clarelli, G Sferruzza, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 30, 2008
A pilot trial of low-dose naltrexone in primary progressive multiple sclerosisM Gironi, F Martinelli-Boneschi, P Sacerdote, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 22, 2022
Methodological and reporting standards for quality-of-life data eligible for European Society for Medical Oncology-Magnitude of Clinical Benefit Scale (ESMO-MCBS) creditS F Oosting, J Barriuso, A Bottomley, et al.
Journal of Neuroimmunology|May 15, 2021
Identification of differential DNA methylation associated with multiple sclerosis: A family-based studyJ M Garcia-Manteiga, F Clarelli, S Bonfiglio, et al.
Pageof 11

Showing results (81-90 of 101) with videos related to

Sort By:
Pageof 11
Lupus|October 10, 2014
Acute longitudinal myelitis following Cryptococcus laurentii pneumonia in a patient with systemic lupus erythematosusF Conti, F R Spinelli, S Colafrancesco, et al.
Molecular Neurobiology|June 28, 2021
Transcriptomic Analysis of Peripheral Monocytes upon Fingolimod Treatment in Relapsing Remitting Multiple Sclerosis PatientsG Sferruzza, F Clarelli, E Mascia, et al.
Oncogene|June 17, 2014
Antisense transcription at the TRPM2 locus as a novel prognostic marker and therapeutic target in prostate cancerU Orfanelli, E Jachetti, F Chiacchiera, et al.
Journal of Neurology|February 14, 2018
Effectiveness and baseline factors associated to fingolimod response in a real-world study on multiple sclerosis patientsF Esposito, L Ferrè, F Clarelli, et al.
Multiple Sclerosis and Related Disorders|July 28, 2018
Neuromyelitis optica spectrum disorder and multiple sclerosis in a Sardinian familyS Gelibter, B Mazzi, M Tassara, et al.
Neurology|June 17, 1999
Relevance of interleukin 1 receptor antagonist intron 2 polymorphism in Italian MS patientsF L Sciacca, C Ferri, K Vandenbroeck, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|May 15, 2018
Basal vitamin D levels and disease activity in multiple sclerosis patients treated with fingolimodL Ferre', F Clarelli, G Sferruzza, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 30, 2008
A pilot trial of low-dose naltrexone in primary progressive multiple sclerosisM Gironi, F Martinelli-Boneschi, P Sacerdote, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 22, 2022
Methodological and reporting standards for quality-of-life data eligible for European Society for Medical Oncology-Magnitude of Clinical Benefit Scale (ESMO-MCBS) creditS F Oosting, J Barriuso, A Bottomley, et al.
Journal of Neuroimmunology|May 15, 2021
Identification of differential DNA methylation associated with multiple sclerosis: A family-based studyJ M Garcia-Manteiga, F Clarelli, S Bonfiglio, et al.
Pageof 11